AIZ
54
-2
MHK
20
2
NEM
28
-6
STX
32
-3
KMX
58
4
CCI
28
-2
FOX
68
-2
MPC
25
2
KIM
56
12
BEN
30
-2
ORLY
45
-3
EMR
50
2
CVX
11
-11
PM
41
-2
KMB
28
3
JPM
53
3
LMT
34
14
WEC
36
5
DOV
46
2
DNB
68
2
AIZ
54
-2
MHK
20
2
NEM
28
-6
STX
32
-3
KMX
58
4
CCI
28
-2
FOX
68
-2
MPC
25
2
KIM
56
12
BEN
30
-2
ORLY
45
-3
EMR
50
2
CVX
11
-11
PM
41
-2
KMB
28
3
JPM
53
3
LMT
34
14
WEC
36
5
DOV
46
2
DNB
68
2
Financhill
Back

Dun & Bradstreet Holdings Vs. Aligos Therapeutics Industry Stock Comparison

Buy
68

DNB
Dun & Bradstreet Holdings

Last Price:
$12.36
Seasonality Move:
-10.34%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$39.78
Seasonality Move:
7.18%
Buy
68
Dun & Bradstreet Holdings (DNB) is a Buy

Is Dun & Bradstreet Holdings a Buy, Sell or Hold?

  • The current Dun & Bradstreet Holdings [DNB] share price is $12.22. The Score for DNB is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • DNB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DNB Stock Price Chart

What is Dun & Bradstreet Holdings's stock price today?

  • The Dun & Bradstreet Holdings share price today is $12.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNB is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $38.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 47.68 Sell
Chaikin Money Flow: -837014 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.19 - 12.61) Sell
Bollinger Bands (100): (11.28 - 12.32) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.1 Buy
Relative Strength Index (14 RSI): 79.33 Buy
Chaikin Money Flow: 265554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.3 - 32.5) Buy
Bollinger Bands (100): (7.16 - 22.66) Buy

DNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.3 Sell
20-day SMA: 12.46 Sell
50-day SMA: 11.98 Buy
200-day SMA: 10.78 Buy
8-day EMA: 12.29 Sell
20-day EMA: 12.32 Sell
50-day EMA: 12.08 Buy
200-day EMA: 11.28 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 28.23 Buy
50-day SMA: 17.95 Buy
200-day SMA: 16.14 Buy
8-day EMA: 33.62 Buy
20-day EMA: 28.8 Buy
50-day EMA: 21.66 Buy
200-day EMA: 17.2 Buy

Dun & Bradstreet Holdings Earnings Growth & DNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.09 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Dun & Bradstreet Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):